Combinati Revenue and Competitors
Estimated Revenue & Valuation
- Combinati's estimated annual revenue is currently $155k per year.
- Combinati's estimated revenue per employee is $155,000
Employee Data
- Combinati has 1 Employees.
- Combinati grew their employee count by 0% last year.
Combinati's People
Name | Title | Email/Phone |
---|---|---|
1 | Software Developer | Reveal Email/Phone |
Combinati Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Combinati?
Combinati believes simplicity shouldn't require sacrificing robustness, quality or rigor – in fact, it should enable it. Our easy-to-use digital PCR platform offers absolute quantification to track disease-relevant biomarkers over time with high accuracy and precision. Comprised of a single instrument and a single consumable, the core microfluidic technology enables partitioning of samples with minimal waste. Combined with the ability to robustly reject false positives and easily adapt traditional qPCR assays, Combinati aims to democratize digital PCR for researchers all over the world.
keywords:N/AN/A
Total Funding
1
Number of Employees
$155k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.1M | 1 | -97% | N/A |
#2 | $0.1M | 1 | -91% | N/A |
#3 | $0.1M | 1 | -83% | N/A |
#4 | $0.1M | 1 | 0% | N/A |
#5 | $0.2M | 1 | -80% | N/A |